With an impressive list of clients, Motilal Oswal Securities Ltd is an established securities firm. `To help people make money in the stock market in an honest way', is the motto of Motilal Oswal Securities which has the trademark sign `more'. The broking outfit has an impressive client list of 15 FIIs, almost 20 domestic mutual funds including UTI, Morgan Stanley Mutual Fund and others and 50 high networth clients, 15-20 corporates. It also services around 2,000 retail clients through sub-brokers or channel partners.

`Around 68 per cent of Motilal Oswal-Inquire recommendations have out-performed the Sensex. Almost 23 stocks recommended by Motilal Oswal-Inquire have outperformed by a margin of more than 20 per cent, while 17 out of 33 `A' group stockswhich hit new high recently are recommended by Motilal Oswal-Inquire as Buy'.

The firm strongly believes that single-minded pursuit of money makes the investor forget that there is a flip-side to this also and that is, losing money. `So it is our endeavour here to help the investor make best investment decisions through availability of research, efficient execution and timely settlement of trade'.

The equity markets create a lot of wealth and according to it, last year itself roughly $6 trillion (Rs 252,00000 crore) was generated in the global premier exchanges. `Indian bourses, too, have a tremendous potential for wealth creation and there is no reason why investors cannot make money in this market'.

The recommendations made by the firm are based on innovation and catching the stock in the early stages of its life-cycle. If the wave is caught early in the life-cycle then the returns on capital employed by these companies are extremely high and sustained for a reasonable period of time and the companybelieves that this is the right period when an investor can make a disproportionately high amount of return on the stock.

The company recommendations are made on the basis of the investors risk profile, time horizon and how much money does the investor have. The recommendations are continuously monitored and whenever the developments are there in these companies, investors are promptly informed. `We have a dedicated team of relationship managers, dedicated sales men who give sales support and dedicated customer service men who give complete support to the investor'.

According to Oswal, volumes from retail clients have gone up substantially post-budget and it seems that the retail investor is trickling back to the equity markets both through the direct route and the mutual fund. The company believes in servicing both the retail and institutional clients on the same basis and does not believe in keeping different standards between the two. `We try to service the retail clients in the same manner as theinstitutional clients'. Post-budget, the level of activity of our existing clients has also improved with increasing participation in the market.

The company believes that today there are at least two businesses which are going to see amazing amount of innovations in the years to come. These two areas are pharmaceutical industry and software sector.

Motila Oswal is known for its pharmaceutical recommendations and according to Oswal, the new patent laws will not only change the rules of the game for the multinationals but will also set a scorching pace of domestic research by well-managed Indian companies.

On of the best recommendation of the firm is Smithkline Pharma which has outperformed the Sensex in the last eight months by 153.84 per cent, Britannia has given a relative return of 114.23 per cent in the last one year, Wartsilla Diesel a return of 55.99 per cent in the last one year, Pfizer 57.91 per cent in the last seven months, Marico 51.32 per cent in the last nine months, Glaxo 127.91 per centin the last thirteen months, E Merck 67.66 per cent in the last seven months, Novartis 57.54 per cent, Smithkline Beecham 54.45 per cent and Digital Equipment Rs 48.58 per cent.

The latest recommendations of the company are MICO Industries and Nestle. We think that in the FMCG sector, Nestle and Marico are good investments and so is HLL which is the time tested and consistent performer. These stocks are slated to appreciate from current levels. Even when the market goes down, these stocks are seldom down. At the current prices, Cipla, Pfizer, E Merck and Burroughs Welcome are attractive even though they have doubled in the last six months. `The patents will be powerful instruments for converting knowledge into wealth with commercialisation of research will earn royalities'. These companies will see a 15 per cent topline growth and 20-25 per cent bottomline growth. There are certain signs of improvement in the economy, Telco is a good buy. The other recoomendations are MRF Tyres, MICO and Hero Honda whichlook good at current levels.

--As told to Parul Monga